These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37909173)

  • 1. Chlorthalidone or Spironolactone for Patients With TRH and Advanced Chronic Kidney Disease?
    Pitt B; Auchus RJ
    Hypertension; 2024 Jan; 81(1):107-109. PubMed ID: 37909173
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients.
    Menon DV; Arbique D; Wang Z; Adams-Huet B; Auchus RJ; Vongpatanasin W
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1361-6. PubMed ID: 19158191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Spironolactone and Chlorthalidone on Cardiovascular Structure and Function in Chronic Kidney Disease: A Randomized, Open-Label Trial.
    Edwards NC; Price AM; Mehta S; Hiemstra TF; Kaur A; Greasley PJ; Webb DJ; Dhaun N; MacIntyre IM; Farrah T; Melville V; Herrey AS; Slinn G; Wale R; Ives N; Wheeler DC; Wilkinson I; Steeds RP; Ferro CJ; Townend JN
    Clin J Am Soc Nephrol; 2021 Oct; 16(10):1491-1501. PubMed ID: 34462286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximizing diuretic therapy in resistant hypertension.
    Handler J
    J Clin Hypertens (Greenwich); 2007 Oct; 9(10):802-6. PubMed ID: 17917510
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypertension in chronic kidney disease-treatment standard 2023.
    Georgianos PI; Agarwal R
    Nephrol Dial Transplant; 2023 Nov; 38(12):2694-2703. PubMed ID: 37355779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.
    Agarwal R; Sinha AD; Cramer AE; Balmes-Fenwick M; Dickinson JH; Ouyang F; Tu W
    N Engl J Med; 2021 Dec; 385(27):2507-2519. PubMed ID: 34739197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cholesterol during treatment of hypertension with diuretic drugs.
    Ames RP; Peacock PB
    Arch Intern Med; 1984 Apr; 144(4):710-4. PubMed ID: 6712367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of arterial hypertension with diuretics].
    Fritel D; Fendler JP
    Sem Ther; 1967; 43(6):381-4. PubMed ID: 5618021
    [No Abstract]   [Full Text] [Related]  

  • 9. [Spironolactone combined with chlorthalidone in the treatment of essential arterial hypertension].
    Gragnoli G; Puccetti F; Tanganelli I; Favilli R; Nami R
    Minerva Med; 1975 Apr; 66(30):1412-6. PubMed ID: 1143685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The behavior of uricemia during treatment with spironolactone and with other diuretics].
    Bufalari A; Meloni G
    Minerva Med; 1967 Nov; 58(89):3815-22. PubMed ID: 6074933
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative studies on spironolactone (Aldactone) and chlorthalidone (Hygroton) in the treatment of arterial hypertension.
    Fris T; Lintrup J; Nissen NI
    Acta Med Scand; 1966 Mar; 179(3):371-81. PubMed ID: 5910857
    [No Abstract]   [Full Text] [Related]  

  • 12. The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease.
    Georgianos PI; Vaios V; Kontogiorgos I; Divani M; Liakopoulos V
    Expert Rev Clin Pharmacol; 2024; 17(5-6):415-418. PubMed ID: 38511397
    [No Abstract]   [Full Text] [Related]  

  • 13. How to treat arterial hypertension.
    Finnerty FA
    Am Fam Physician; 1973 Apr; 7(4):99-108. PubMed ID: 4694341
    [No Abstract]   [Full Text] [Related]  

  • 14. [A comparative study of spironolactone and chlorthalidone in treatment of hypertension].
    Fagerberg SE; Göransson K
    Lakartidningen; 1974 Jan; 71(3):175-7. PubMed ID: 4837216
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypertension--diuretics as antihypertensive agents].
    Ikeda T
    Nihon Rinsho; 1970 Apr; 28(4):1266-71. PubMed ID: 4913896
    [No Abstract]   [Full Text] [Related]  

  • 16. Modifying elevated blood pressure: a practical office approach.
    Tobian L
    Minn Med; 1969 Aug; 52(8):1307-10. PubMed ID: 5805001
    [No Abstract]   [Full Text] [Related]  

  • 17. Chlorthalidone for Resistant Hypertension in Advanced Chronic Kidney Disease.
    Agarwal R; Sinha AD; Tu W
    Circulation; 2022 Aug; 146(9):718-720. PubMed ID: 36037270
    [No Abstract]   [Full Text] [Related]  

  • 18. Spironolactone increases serum uric acid levels in patients with chronic kidney disease.
    Cabrera SE; Edwards NC; Steeds RP; Townend JN; Ferro CJ
    J Hum Hypertens; 2014 Mar; 28(3):210-1. PubMed ID: 23863804
    [No Abstract]   [Full Text] [Related]  

  • 19. Potassium deficiency in hypertensives treated with diuretics. Analysis of three alternative treatments by an oral test for potassium deficiency.
    Berg KJ; Gisholt K; Wideroe TE
    Eur J Clin Pharmacol; 1974 Oct; 7(6):401-5. PubMed ID: 4439864
    [No Abstract]   [Full Text] [Related]  

  • 20. Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone.
    Vaughan ED; Laragh JH; Gavras I; Bühler FR; Gavras H; Brunner HR; Baer L
    Am J Cardiol; 1973 Sep; 32(4):523-32. PubMed ID: 4729722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.